QuidelOrtho
QDEL
$84.62
Share price
-2.11%
Change (1 day)
-13.23%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
EPS for QuidelOrtho (QDEL)
EPS in 2023 (TTM): $1.85
According to QuidelOrtho's latest financial reports the company's current EPS (TTM) is $1.85. In 2022 the company made an earnings per share (EPS) of $12.58 a decrease over its 2021 EPS that were of $16.80.
EPS history for QuidelOrtho from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.85 | -85.29% |
| 2022 | $12.58 | -25.12% |
| 2021 | $16.80 | -12.64% |
| 2020 | $19.23 | 980.34% |
| 2019 | $1.78 | -10.1% |
| 2018 | $1.98 | -960.87% |
| 2017 | -$0.23 | |
| 2015 | -$0.17 | -15% |
| 2014 | -$0.20 | -190.91% |
| 2013 | $0.22 | 46.67% |
| 2012 | $0.15 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $15.44 | 734.59% | 🇺🇸 USA |
 Becton Dickinson BDX | $5.36 | 189.73% | 🇺🇸 USA |
 Danaher DHR | $9.40 | 408.11% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.59 | 148.07% | 🇺🇸 USA |
 OraSure Technologies OSUR | -$0.26 | -114.05% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.97 | -47.57% | 🇺🇸 USA |